Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 633

1.

Treatment of isolated systolic hypertension: the SHELL study results.

Malacco E, Mancia G, Rappelli A, Menotti A, Zuccaro MS, Coppini A; Shell Investigators.

Blood Press. 2003;12(3):160-7.

PMID:
12875478
[PubMed - indexed for MEDLINE]
2.

Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study.

Payeras AC, Sladek K, Lembo G, Alberici M.

Clin Drug Investig. 2007;27(9):623-32.

PMID:
17705571
[PubMed - indexed for MEDLINE]
3.

Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).

JATOS Study Group.

Hypertens Res. 2008 Dec;31(12):2115-27. doi: 10.1291/hypres.31.2115.

PMID:
19139601
[PubMed - indexed for MEDLINE]
4.

Lacidipine, hydrochlorothiazide and their combination in systolic hypertension in the elderly.

Wing LM, Arnolda LF, Harvey PJ, Upton J, Molloy D, Bune AJ, Chalmers JP.

J Hypertens. 1997 Dec;15(12 Pt 1):1503-10.

PMID:
9431858
[PubMed - indexed for MEDLINE]
5.

Systolic hypertension in the elderly: long-term lacidipine treatment. Objective, protocol, and organization. SHELL Study Group.

Malacco E, Gnemmi AE, Romagnoli A, Coppini A.

J Cardiovasc Pharmacol. 1994;23 Suppl 5:S62-6.

PMID:
7609510
[PubMed - indexed for MEDLINE]
6.

Additive hypotensive effect of a dihydropyridine calcium antagonist to that produced by a thiazide diuretic: a double-blind placebo-controlled crossover trial with ambulatory blood pressure monitoring.

Stergiou GS, Malakos JS, Achimastos AD, Mountokalakis TD.

J Cardiovasc Pharmacol. 1997 Mar;29(3):412-6.

PMID:
9125681
[PubMed - indexed for MEDLINE]
8.

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial.

Staessen JA, Thijisq L, Fagard R, Celis H, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Fletcher AE, Forette F, Leonetti G, McCormack P, Nachev C, O'Brien E, Rodicio JL, Rosenfeld J, Sarti C, Tuomilehto J, Webster J, Yodfat Y, Zanchetti A; Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

J Hypertens. 2004 Apr;22(4):847-57.

PMID:
15126928
[PubMed - indexed for MEDLINE]
9.

The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): protocol, patient characteristics, and blood pressure during the first 12 months.

JATOS Study Group.

Hypertens Res. 2005 Jun;28(6):513-20. Erratum in: Hypertens Res. 2005 Oct;28(10):857.

PMID:
16231757
[PubMed - indexed for MEDLINE]
10.

Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators.

Rosei EA, Dal Palù C, Leonetti G, Magnani B, Pessina A, Zanchetti A.

J Hypertens. 1997 Nov;15(11):1337-44.

PMID:
9383184
[PubMed - indexed for MEDLINE]
11.

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

Liu L, Wang JG, Gong L, Liu G, Staessen JA.

J Hypertens. 1998 Dec;16(12 Pt 1):1823-9.

PMID:
9869017
[PubMed - indexed for MEDLINE]
12.

Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.

Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B.

Curr Med Res Opin. 2007 Feb;23(2):259-70.

PMID:
17288679
[PubMed - indexed for MEDLINE]
13.

Lercanidipine vs lacidipine in isolated systolic hypertension.

Millar-Craig M, Shaffu B, Greenough A, Mitchell L, McDonald C.

J Hum Hypertens. 2003 Nov;17(11):799-806.

PMID:
14578921
[PubMed - indexed for MEDLINE]
14.

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.

Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A; FEVER Study Group.

J Hypertens. 2005 Dec;23(12):2157-72.

PMID:
16269957
[PubMed - indexed for MEDLINE]
15.

The Hypertension Optimal Treatment study and the importance of lowering blood pressure.

Hansson L.

J Hypertens Suppl. 1999 Feb;17(1):S9-13.

PMID:
10340838
[PubMed - indexed for MEDLINE]
16.

Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial.

Davis BR, Cutler JA, Furberg CD, Wright JT, Farber MA, Felicetta JV, Stokes JD; ALLHAT Collaborative Research Group.

Ann Intern Med. 2002 Sep 3;137(5 Part 1):313-20.

PMID:
12204014
[PubMed - indexed for MEDLINE]
17.

Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension.

Grimm RH Jr, Black H, Rowen R, Lewin A, Shi H, Ghadanfar M; Amlodipine Study Group.

Am J Hypertens. 2002 Jan;15(1 Pt 1):31-6.

PMID:
11824857
[PubMed - indexed for MEDLINE]
19.
20.

Safety of the calcium antagonist lacidipine evaluated from a phase III-IV trial database.

Lindholm LH, Tcherdakoff P, Zanchetti A.

J Hypertens Suppl. 1996 Sep;14(2):S15-20.

PMID:
8934373
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk